Simulations Plus Sets Date for 3rd Quarter 2015 Earnings Release and Conference Call

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, announced that it expects to file its quarterly report on Form 10-Q for the third quarter of its 2015 fiscal year ended May 31, 2015, with the U.S. Securities and Exchange Commission on Monday, July 13, 2015. Dr. Ted Grasela, president, and Walt Woltosz, chairman and CEO, will host a conference call to discuss the Company’s performance on Monday, July 13, 2015, at 1:15 p.m. PDT / 4:15 p.m. EDT.

The conference call will be webcast live and may be joined by registering at: https://attendee.gotowebinar.com/register/7514990819733113602. After registering, you will receive a confirmation email containing information about joining the webinar. Please dial in five to ten minutes prior to the scheduled start time. For listen-only mode, you may dial 415-655-0059, and enter access code 307-841-003.

About Simulations Plus, Inc.

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software which is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide. Simulations Plus recently acquired Cognigen Corporation, adding top quality modeling and simulations using clinical trial data to our offerings. The acquisition more than doubled our staff and added significantly to revenues. The Company is headquartered in Southern California and trades on the NASDAQ Capital Market under the symbol “SLP.” Cognigen Corp. is located in Buffalo, New York. For more information, visit our Web site at www.simulations-plus.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150708005437/en/